Some studies reported that SBNO2 increases the risk of cardiovascular disease and type 2 diabetes by increasing BMI [10, 11], but the mechanism by which SBNO2 leads to GC has not yet been revealed. This evidence concerns the gene SBNO2 and type 2 diabetes mellitus.